Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B4DL
|
|||
| Former ID |
DIB001481
|
|||
| Drug Name |
CRS-100
|
|||
| Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 1 | [1] | |
| Company |
Cerus
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00327652) Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.